FDA Approves New OTC Naloxone Nasal Spray for Emergency Use

The opioid overdose reversal drug is a generic of OTC Narcan.

APRIL 29, 2024

Decreased Opioid Prescribing Not a Silver Bullet for Reducing Overdose Deaths

Opioid prescribing has fallen by nearly 50% over the past 10 years, but opioid-related overdose deaths continue to ...

MARCH 5, 2024

California Governor Vetoes Bill Requiring Insurance to Cover Low-Cost Naloxone

A bill that would require California insurers to cover the cost of OTC naloxone was vetoed by the state’s ...

OCTOBER 31, 2023

CBD Could Help Naloxone Reverse Opioid Overdoses

Cannabidiol may be beneficial in reversing opioid overdose when used in conjunction with naloxone, according to new ...

MAY 13, 2023

‘We Are Saving Lives’: The Long Journey to FDA Approval for OTC Naloxone

Efforts to increase access to naloxone—even for harm reduction programs—were still meeting distribution ...

APRIL 4, 2023

FDA Approves OTC Version of Opioid Overdose Reversal Agent

The FDA approved the OTC version of naloxone nasal spray to rapidly reverse the effects of opioid overdose.

APRIL 3, 2023

Telehealth Services During COVID-19 Associated With Reduced Risk for Fatal Overdose

The expanded availability of telehealth services and medications for opioid use disorder (OUD) during the COVID-19 ...

MARCH 31, 2023

Drug Testing Gap Spurs a Different COVID Crisis

In addition to the millions of lives claimed by COVID-19, another group of victims has emerged: the users and ...

DECEMBER 9, 2021

FDA Warns of Continued Dangers of Accidental Exposure to Fentanyl Patches in Children

In an effort to reduce potential accidental exposure to children, the FDA is again urging caution regarding the ...

SEPTEMBER 22, 2021

FDA Awards Contract to Develop Opioid Use Guidelines

The National Academies of Sciences, Engineering, and Medicine will be tasked with helping to develop evidence-based ...

AUGUST 22, 2018